BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 113918
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.113918
Table 1 Suggested indications for endoscopic submucosal dissection by the European Society of Gastrointestinal Endoscopy
Organ

Indications for ESD
EsophagusSquamous cell carcinomaHGD to well (G1) to moderately (G2) differentiated; Paris 0-II lesions; Absolute indications: M1-m2 involvement with 2/3 or less of the esophageal circumference; Expanded indications: M3 or sm
Barrett’s esophagusHGD to moderately (G1 or G2) differentiated T1a (m1-m3) lesions 15 mm (not amenable to en bloc resection by EMR); Patients with Barrett’s esophagus and the following features: Large or bulky area of nodularity; equivocal preprocedural histology; intramucosal carcinoma; suspected superficial submucosal invasion; recurrent dysplasia; and EMR specimen showing invasive carcinoma with positive margins
StomachMucosal adenocarcinoma (and lesions with HGD), intestinal type, G1 or G2 differentiation, size < or 2 cm, no ulceration. Expanded indications: Adenocarcinoma, intestinal type, G1 or G2 differentiation, any size, without ulceration; adenocarcinoma, intestinal type, G1 or G2 differentiation, sm-invasive (< 500 μm); adenocarcinoma, intestinal type, G1 or G2 differentiation, 3 cm, with ulceration; and adenocarcinoma, diffuse type, G3 or G4 differentiation, size 2 cm, without ulceration
Colon and rectumEn bloc resection for lesions at risk for submucosally invasive cancer: Type V Kudo pit pattern, depressed component (Paris 0-IIc), complex morphology (0-Is or 0-IIaþIs), rectosigmoid location: Nongranular LST (adenomas), 20 mm in size granular LST (adenomas), 30 mm in size; Residual or recurrent colorectal adenomas


Write to the Help Desk